Key result
Radiofrequency catheter ablation for ventricular arrhythmias in patients with prior mitral valve surgery achieved an overall 1-year recurrence-free rate of 72.2% without complications.
Why the study?
Data regarding VT or PVC ablation following MVS are limited, and catheter ablation can be challenging due to perivalvular substrate with mitral annuloplasty or prosthetic valves.
Is radiofrequency catheter ablation safe and effective for treating ventricular arrhythmias in patients with prior mitral valve surgery?
Cohort (n=31)
Is radiofrequency catheter ablation safe and effective for treating ventricular arrhythmias in patients with prior mitral valve surgery?
Catheter ablation of ventricular arrhythmias can be performed safely and effectively in patients with prior mitral valve surgery, achieving a 72.2% recurrence-free rate at 1 year without procedure-related complications.
May support ablation feasibility after mitral valve surgery; leaves open need for randomized confirmation.
Background: Data regarding ventricular tachycardia (VT) or premature ventricular complex (PVC) ablation following MVS is limited.) CA can be challenging given perivalvular substrate in the setting of mitral annuloplasty or prosthetic valves. Objective: To investigate the characteristics, safety, and outcomes of radiofrequency catheter ablation (CA) in patients with prior mitral valve surgery (MVS) and ventricular arrhythmias (VA). Methods: We identified consecutive patients with prior MVS who underwent CA for VT or PVC between January 2013- December 2018. We investigated the mechanism of arrhythmia, ablation approach, peri-operative complications, and outcomes. Results: In our cohort of 31 patients (77% men, mean age 62.3±10.8 years, left ventricular ejection fraction 39.2±13.9%) with prior MVS underwent CA (16 VT; 15 PVC). Access to the left ventricle was via transseptal approach in 17 patients, and a retrograde aortic approach was used in 13 patients. A combined transseptal and retrograde aortic approach was used in one patient, and a percutaneous epicardial approach was combined with trans-septal approach in 1patient. Heterogenous scar regions were present in 94% of VT patients and scar-related reentry was the dominant mechanism of VT. Clinical VA substrates involved the peri-mitral area in 6 patients with VT and 5 patients with PVC ablation. No procedure-related complications were reported. The overall recurrence-free rate at 1-year was 72.2%; 67% in the VT group and 78% in the PVC group. No arrhythmia-related death was documented on long-term follow-up. Conclusion: CA of VAs can be performed safely and effectively in patients with MVS
No takes yet. Share an insight, caveat, or question.
Khalil et al. (2021) conducted a cohort in Ventricular arrhythmias (VT or PVC) with prior mitral valve surgery (n=31). Radiofrequency catheter ablation was evaluated on Overall recurrence-free rate at 1-year. Radiofrequency catheter ablation for ventricular arrhythmias in patients with prior mitral valve surgery achieved an overall 1-year recurrence-free rate of 72.2% without complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: